SCHEMBL1476768

SCHEMBL1476768

O=C(O)C1CC=CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18576616 1.00
SCHEMBL15330936 1.00
Hydrochloric Acid SCHEMBL9143086 0.98 EGLN1 (0.45)
SCHEMBL6242999 0.79
SCHEMBL1661673 0.78
SCHEMBL2455796 0.78
SCHEMBL1663681 0.78
SCHEMBL7390062 0.77 EGLN1 (0.43)
SCHEMBL4872602 0.77 CYP2D6 (0.37)
Hydrochloric Acid SCHEMBL28033013 0.77 EGLN1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9101662-B2 Compositions with modulating agents FOAMIX PHARMACEUTICALS LTD. (IL) 2015-08-11 US claimed
US-8795693-B2 Compositions with modulating agents FOAMIX LTD. (IL) 2014-08-05 US claimed
EP-2097065-A2 FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS Foamix Ltd. (IL) 2009-09-09 EP claimed
WO-2008152444-A2 FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS FOAMIX LTD. (US) 2008-12-18 WO claimed
US-20080206159-A1 Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions FOAMIX LTD. (IL) 2008-08-28 US claimed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 US claimed
EP-0078191-B1 COLLAGEN INHIBITING COMPOSITIONS AND PROCESSES FOR MANUFACTURING AND USING THE SAME UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 1986-09-03 EP claimed
US-4428939-A POLYMERIC HYDROXYPROLINE FOR REDUCTION OF SCAR TISSUE COLLEGE OF MEDICINE AND DENTISTRY OF NEW JERSEY 1984-01-31 US claimed
EP-0078191-A2 Collagen inhibiting compositions and processes for manufacturing and using the same UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 1983-05-04 EP claimed
US-20250353926-A1 CROSSLINKING MULTISPECIFIC ANTIBODIES ENLAZA THERAPEUTICS INC (US) 2025-11-20 US disclosed
EP-4532564-A1 CROSSLINKING MULTISPECIFIC ANTIBODIES Enlaza Therapeutics, Inc. (US) 2025-04-09 EP disclosed
CN-119731211-A Cross-linked multispecific antibodies 恩拉扎治疗公司 2025-03-28 CN disclosed
CN-118922209-A Cross-linked antibodies 恩拉扎治疗公司 2024-11-08 CN disclosed
EP-4452333-A1 CROSSLINKING ANTIBODIES Enlaza Therapeutics, Inc. (US) 2024-10-30 EP disclosed
US-4217458-A Acylmercaptoacyl derivatives of 4,5-dihydro-1H-pyrrole-2-carboxylic acids and 1,4,5,6-tetrahydropyridine-2-carboxylic acids E. R. SQUIBB & SONS, INC. (US) 1980-08-12 US disclosed
US-4198515-A Mercaptoacyl derivatives of 4,5-dihydro-1H-pyrrole-2-carboxylic acids and 1,4,5,6-tetrahydropyridine-2-carboxylic acids E. R. SQUIBB & SONS, INC. (US) 1980-04-15 US disclosed
US-4156084-A Certain dimers of tetrahydropyridine-2-carboxylic acids or pyrroline-2-carboxylic acids and derivatives thereof E. R. SQUIBB & SONS, INC. (US) 1979-05-22 US disclosed
US-4154942-A Certain tetrahydropyridine-2-carboxylic acids and pyrroline-2-carboxylic acids and derivatives thereof E. R. SQUIBB & SONS, INC. (US) 1979-05-15 US disclosed
US-4129566-A Derivatives of dehydrocyclicimino acids E. R. SQUIBB & SONS, INC. (US) 1978-12-12 US disclosed
US-3957760-A AMINO ACID DERIVATIVES E. R. SQUIBB & SONS, INC. (US) 1976-05-18 US disclosed